Pharmagreen Biotech Inc. Annual Operating Income (Loss) in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pharmagreen Biotech Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2022.
  • Pharmagreen Biotech Inc. Operating Income (Loss) for the quarter ending March 31, 2023 was -$188K, a 81.9% increase year-over-year.
  • Pharmagreen Biotech Inc. Operating Income (Loss) for the twelve months ending March 31, 2023 was -$231K, a 86.8% increase year-over-year.
  • Pharmagreen Biotech Inc. annual Operating Income (Loss) for 2022 was -$1.1M, a 48% decline from 2021.
  • Pharmagreen Biotech Inc. annual Operating Income (Loss) for 2021 was -$744K, a 53.2% decline from 2020.
  • Pharmagreen Biotech Inc. annual Operating Income (Loss) for 2020 was -$486K, a 24.4% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$1.1M -$357K -48% Oct 1, 2021 Sep 30, 2022 10-K 2023-01-17
2021 -$744K -$258K -53.2% Oct 1, 2020 Sep 30, 2021 10-K 2023-01-17
2020 -$486K +$156K +24.4% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-29
2019 -$642K +$107K +14.2% Oct 1, 2018 Sep 30, 2019 10-K 2021-01-08
2018 -$749K Oct 1, 2017 Sep 30, 2018 10-K 2019-12-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.